speb/financial-data huggingface dataset:
Financial ratios for BOXL — annual report dated 2023-12-31
Total revenue: 176721000
Gross profit: 63302000
Operating income: -1105000
Net income: -39156000
Capital expenditures: 1321000
Operating cash flow: 11581000
Depreciation & amortization: 8859000
Net tangible assets: -29213000
Owner earnings: -31618000
Buffett classification: The Gruesome
Stock price: 192.6
Shares outstanding: 667057
Book value: 16751000
P/B ratio: 7.669701999880604
Market cap (USD): 128475178.2
Debt to equity: 2.9419139155871292
Current ratio: 2.0953190112068616
Quick ratio: 1.2025933567989642
Interest coverage ratio: -0.10193726937269372
COGS to revenue (%): 64.17969567849887
R&D to revenue (%): 1.785299992643772
SG&A to revenue (%): 34.660283724062225
Free cash flow (dilution-adjusted): 7129000
Buyback yield (%): 0
Retained earnings: -104275000
Inventory turnover: 2.5700527973533345
Receivables turnover: 5.409605730378352
Capitalized R&D asset: 4817940
ROCI (R&D-adjusted, %): 0.14595806274899295
Rosenberg metric: -0.6309427880741337
FCF margin (%): 4.034042360557036
Revenue growth (%): -20.31734007872631
Rule of 40 score: -16.283297718169273
Financial ratios for BOXL — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 2075000
Buffett classification: The Gruesome
Stock price: 95.4
Shares outstanding: 667057
Market cap (USD): 63637237.800000004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BOXL — annual report dated 2024-12-31
Total revenue: 135893000
Gross profit: 46941000
Operating income: -19470000
Net income: -28335000
Capital expenditures: 506000
Operating cash flow: -439000
Depreciation & amortization: 20529000
Net tangible assets: -38840000
Owner earnings: -8312000
Buffett classification: The Gruesome
Stock price: 68.76
Shares outstanding: 667057
Book value: -12896000
Market cap (USD): 45866839.32
Debt to equity: -3.535514888337469
Current ratio: 1.0174195223260645
Quick ratio: 0.4558281412253375
Interest coverage ratio: -1.8991416309012876
COGS to revenue (%): 65.45738191076804
R&D to revenue (%): 3.036212314100064
SG&A to revenue (%): 30.727116187000064
Free cash flow (dilution-adjusted): -2334000
Buyback yield (%): 0
Retained earnings: -132610000
Inventory turnover: 2.0559805847682884
Receivables turnover: 7.415716234652114
Capitalized R&D asset: 7058910
ROCI (R&D-adjusted, %): -41.03426499022995
Rosenberg metric: -5.185736925515055
FCF margin (%): -1.7175277608118151
Revenue growth (%): -23.103083391334366
Rule of 40 score: -24.82061115214618
Financial ratios for BOXL — quarterly report dated 2024-12-31
Capital expenditures: 227000
Buffett classification: The Gruesome
Stock price: 68.76
Shares outstanding: 667057
Market cap (USD): 45866839.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BOXL — quarterly report dated 2025-03-31
Total revenue: 22423000
Gross profit: 8043000
Operating income: -2908000
Net income: -3243000
Capital expenditures: 127000
Operating cash flow: -4680000
Depreciation & amortization: 2463000
Net tangible assets: -39849000
Owner earnings: -907000
Buffett classification: The Gruesome
Stock price: 52.56
Shares outstanding: 667057
Book value: -15815000
Market cap (USD): 35060515.92
Debt to equity: -3.0270629149541572
Current ratio: 1.0222550903335499
Quick ratio: 0.49208631104598927
Interest coverage ratio: -1.1692802573381584
COGS to revenue (%): 64.13058020782233
R&D to revenue (%): 4.067252374793739
SG&A to revenue (%): 33.78673683271641
Free cash flow (dilution-adjusted): -4976000
Buyback yield (%): 0
Retained earnings: -135853000
Inventory turnover: 0.37492829952547324
Receivables turnover: 1.2854276542077505
Capitalized R&D asset: 912000
ROCI (R&D-adjusted, %): -6.172011270629277
FCF margin (%): -22.191499799313206
Rule of 40 score: -22.191499799313206
Financial ratios for BOXL — quarterly report dated 2025-06-30
Total revenue: 30852000
Gross profit: 10790000
Operating income: -3912000
Net income: -4719000
Capital expenditures: 32000
Operating cash flow: 1580000
Depreciation & amortization: 2591000
Net tangible assets: -42955000
Owner earnings: -2160000
Buffett classification: The Gruesome
Stock price: 63.36
Shares outstanding: 667057
Book value: -20629000
Market cap (USD): 42264731.52
Debt to equity: -2.299045033690436
Current ratio: 0.9918936737690671
Quick ratio: 0.5694956396655578
Interest coverage ratio: -1.5215869311551926
COGS to revenue (%): 65.02657850382472
R&D to revenue (%): 3.6561649163749514
SG&A to revenue (%): 43.99714767276027
Free cash flow (dilution-adjusted): 1369000
Buyback yield (%): 0
Retained earnings: -140572000
Inventory turnover: 0.7116708052500886
Receivables turnover: 1.439059657633285
Capitalized R&D asset: 1739040
ROCI (R&D-adjusted, %): -10.128050841411799
Rosenberg metric: 3.012061403508772
FCF margin (%): 4.437313626345132
Revenue growth (%): 37.59086652098292
Rule of 40 score: 42.02818014732805
Financial ratios for BOXL — quarterly report dated 2025-09-30
Total revenue: 29337000
Gross profit: 8535000
Operating income: -3944000
Net income: -6184000
Capital expenditures: 1000
Operating cash flow: 1292000
Depreciation & amortization: 2627000
Net tangible assets: -39040000
Owner earnings: -3558000
Buffett classification: The Gruesome
Stock price: 86.76
Shares outstanding: 667057
Book value: -19463000
Market cap (USD): 57873865.32
Debt to equity: -2.2853619688639983
Current ratio: 1.0222638034119316
Quick ratio: 0.6412209276828394
Interest coverage ratio: -1.432618961133309
COGS to revenue (%): 70.90704571019532
R&D to revenue (%): 3.824521934758155
SG&A to revenue (%): 29.75764393087228
Free cash flow (dilution-adjusted): 1182000
Buyback yield (%): 0
Retained earnings: -146756000
Inventory turnover: 0.7980511010511778
Receivables turnover: 1.4907012195121951
Capitalized R&D asset: 2178720
ROCI (R&D-adjusted, %): -11.618106020912592
Rosenberg metric: -1.999113475177305
FCF margin (%): 4.029041824317415
Revenue growth (%): -4.910540645663166
Rule of 40 score: -0.8814988213457511
Financial ratios for BOXL — quarterly report dated 2025-12-31
Total revenue: 26634000
Gross profit: 6261000
Operating income: -5610000
Net income: -9664000
Capital expenditures: 56000
Operating cash flow: -1527000
Depreciation & amortization: 2599000
Net tangible assets: -15825000
Owner earnings: -7121000
Buffett classification: The Gruesome
Stock price: 10.2
Shares outstanding: 667057
Book value: 1255000
P/B ratio: 5.421499123505975
Market cap (USD): 6803981.399999999
Debt to equity: 33.101195219123504
Current ratio: 1.621347895080743
Quick ratio: 0.7316344628022029
Interest coverage ratio: -2.525889239081495
COGS to revenue (%): 76.49245325523766
R&D to revenue (%): 4.156341518359992
SG&A to revenue (%): 30.65630397236615
Free cash flow (dilution-adjusted): -1281000
Buyback yield (%): 0
Retained earnings: -156420000
Inventory turnover: 0.5343597544982427
Receivables turnover: 1.7342101836176584
Capitalized R&D asset: 2230980
ROCI (R&D-adjusted, %): -9.87667681271804
Rosenberg metric: -2.0267379679144386
FCF margin (%): -4.809641811218743
Revenue growth (%): -9.213621024644647
Rule of 40 score: -14.02326283586339
Financial ratios for BOXL — annual report dated 2025-12-31
Total revenue: 109246000
Gross profit: 33629000
Operating income: -16374000
Net income: -23810000
Capital expenditures: 102000
Operating cash flow: -3335000
Depreciation & amortization: 10280000
Net tangible assets: -15825000
Owner earnings: -13632000
Buffett classification: The Gruesome
Stock price: 10.2
Shares outstanding: 667057
Book value: 1255000
P/B ratio: 5.421499123505975
Market cap (USD): 6803981.399999999
Debt to equity: 33.101195219123504
Current ratio: 1.621347895080743
Quick ratio: 0.7316344628022029
Interest coverage ratio: -1.632177033492823
COGS to revenue (%): 69.21717957636892
R&D to revenue (%): 3.9076945608992544
SG&A to revenue (%): 32.45336213682881
Free cash flow (dilution-adjusted): -3706000
Buyback yield (%): 0
Retained earnings: -156420000
Inventory turnover: 1.983344699155432
Receivables turnover: 7.1132960020836045
Capitalized R&D asset: 8074570
ROCI (R&D-adjusted, %): -25.419987423041007
Rosenberg metric: -3.2263693650024234
FCF margin (%): -3.3923438844442813
Revenue growth (%): -19.608809872473195
Rule of 40 score: -23.001153756917475
Financial ratios for CCB.V — annual report dated 2021-12-31
Total revenue: 0
Operating income: -571376.3779527559
Net income: -542286.6141732284
Capital expenditures: 281718.89763779525
Operating cash flow: -210245.6692913386
Net tangible assets: 5664151.181102362
Owner earnings: -824005.5118110236
Return on net tangible assets (%): -14.54773160999306
Buffett classification: The Gruesome
Stock price: 0.06299212598425197
Shares outstanding: 242281512
Book value: 5664151.1811023615
P/B ratio: 2.6944597768643574
Market cap (USD): 15261827.527559055
Debt to equity: 0
Current ratio: 1.0892512164035844
Quick ratio: 1.0892512164035844
Free cash flow (dilution-adjusted): -647948.8188976378
Buyback yield (%): 0
Retained earnings: -22302660.62992126
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.045695477188808
Rule of 40 score: 0
Financial ratios for CCB.V — annual report dated 2022-12-31
Total revenue: 0
Operating income: -887930.1470588235
Net income: -737140.4411764705
Capital expenditures: 648040.4411764705
Operating cash flow: -612984.5588235294
Net tangible assets: -255400.73529411762
Owner earnings: -1385180.882352941
Buffett classification: The Gruesome
Stock price: 0.044117647058823525
Shares outstanding: 242281512
Book value: -255400.7352941177
Market cap (USD): 10688890.235294117
Debt to equity: 0
Current ratio: 0.7227259014498064
Quick ratio: 0.7227259014498064
Free cash flow (dilution-adjusted): -1265094.1176470588
Buyback yield (%): 0
Retained earnings: -27101354.411764704
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCB.V — annual report dated 2023-12-31
Total revenue: 0
Operating income: -1748623.4848484849
Net income: -1581815.909090909
Capital expenditures: 790152.2727272727
Operating cash flow: -1197534.0909090908
Net tangible assets: -835868.9393939393
Owner earnings: -2371968.1818181816
Buffett classification: The Gruesome
Stock price: 0.030303030303030304
Shares outstanding: 242281512
Book value: -835868.9393939395
Market cap (USD): 7341864
Debt to equity: 0
Current ratio: 0.31816532949683535
Quick ratio: 0.31816532949683535
Free cash flow (dilution-adjusted): -1311863.6363636362
Buyback yield (%): 0
Retained earnings: -29347836.363636363
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCB.V — quarterly report dated 2024-09-30
Total revenue: 0
Operating income: -201453.3333333333
Net income: -200918.5185185185
Capital expenditures: 2378.5185185185182
Operating cash flow: -41064.444444444445
Net tangible assets: 5888446.666666666
Owner earnings: -203297.03703703702
Return on net tangible assets (%): -3.4524730976653215
Buffett classification: The Gruesome
Stock price: 0.014814814814814814
Shares outstanding: 242281512
Book value: 5888446.666666666
P/B ratio: 0.6095590121673288
Market cap (USD): 3589355.733333333
Debt to equity: 0
Current ratio: 0.07215147684799253
Quick ratio: 0.07215147684799253
Free cash flow (dilution-adjusted): -41064.444444444445
Buyback yield (%): 0
Retained earnings: -22432187.407407407
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.40830009463114
Rule of 40 score: 0
Financial ratios for CCB.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -501495.80419580423
Net income: -423341.25874125876
Capital expenditures: 0
Operating cash flow: -381363.63636363635
Net tangible assets: -854819.5804195805
Owner earnings: -423341.25874125876
Buffett classification: The Gruesome
Stock price: 0.013986013986013988
Shares outstanding: 242281512
Book value: -854819.5804195805
Market cap (USD): 3388552.615384616
Debt to equity: 0
Current ratio: 0.22956107032111517
Quick ratio: 0.22956107032111517
Free cash flow (dilution-adjusted): -292365.034965035
Buyback yield (%): 0
Retained earnings: -27882347.552447554
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCB.V — annual report dated 2024-12-31
Total revenue: 0
Operating income: -974123.7762237763
Net income: -883320.979020979
Capital expenditures: 0
Operating cash flow: -983768.5314685315
Net tangible assets: -854819.5804195805
Owner earnings: -883320.979020979
Buffett classification: The Gruesome
Stock price: 0.013986013986013988
Shares outstanding: 242281512
Book value: -854819.5804195805
Market cap (USD): 3388552.615384616
Debt to equity: 0
Current ratio: 0.22956107032111517
Quick ratio: 0.22956107032111517
Free cash flow (dilution-adjusted): -983768.5314685315
Buyback yield (%): 0
Retained earnings: -27882347.552447554
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCB.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -646006.2937062937
Net income: -645430.06993007
Capital expenditures: 0
Operating cash flow: -116408.39160839161
Net tangible assets: -1500249.6503496503
Owner earnings: -645430.06993007
Buffett classification: The Gruesome
Stock price: 0.013986013986013988
Shares outstanding: 242281512
Book value: -1500249.6503496505
Market cap (USD): 3388552.615384616
Debt to equity: 0
Current ratio: 0.034615985855514946
Quick ratio: 0.034615985855514946
Free cash flow (dilution-adjusted): -116408.39160839161
Buyback yield (%): 0
Retained earnings: -28527777.622377623
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCB.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -135884.6715328467
Net income: -140827.73722627736
Capital expenditures: 0
Operating cash flow: -15044.525547445255
Net tangible assets: -1706781.7518248174
Owner earnings: -140827.73722627736
Buffett classification: The Gruesome
Stock price: 0.0072992700729927005
Shares outstanding: 242281512
Book value: -1706781.7518248174
Market cap (USD): 1768478.1897810218
Debt to equity: 0
Current ratio: 0.010504857609409756
Quick ratio: 0.010504857609409756
Free cash flow (dilution-adjusted): -15044.525547445255
Buyback yield (%): 0
Retained earnings: -29917997.080291968
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLV.AX — annual report dated 2021-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.1925925925925926
Shares outstanding: 166999341
Market cap (USD): 199162177.04444444
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLV.AX — annual report dated 2022-07-31
Total revenue: 49412587.41258741
Gross profit: 15057342.657342657
Operating income: 7275524.475524476
Net income: 4988111.888111888
Capital expenditures: 1117482.5174825175
Depreciation & amortization: 497902.0979020979
Net tangible assets: 42750349.650349654
Owner earnings: 4368531.468531469
Return on net tangible assets (%): 10.218703482570788
Capex to operating income (%): 15.359477124183007
Buffett classification: The Great
Stock price: 0.6993006993006994
P/E ratio: 23.412216598906493
Shares outstanding: 166999341
Book value: 44083916.08391608
P/B ratio: 2.6491012214467005
Market cap (USD): 116782755.94405596
Debt to equity: 0.19159263959390863
Current ratio: 3.8766162231112657
Quick ratio: 1.7913260277149647
Effective tax rate (%): 27.510162601626014
Interest coverage ratio: 22.865934065934066
COGS to revenue (%): 69.5273138975375
R&D to revenue (%): 2.628078120577413
SG&A to revenue (%): 12.112935182564396
Free cash flow (dilution-adjusted): 3485314.6853146856
Buyback yield (%): 0
Retained earnings: 19893706.293706294
Inventory turnover: 1.3659947170860558
Receivables turnover: 3.6121051017278396
Capitalized R&D asset: 1298601.3986013986
ROCI (R&D-adjusted, %): 15.478501342835111
FCF margin (%): 7.05349561279366
Rule of 40 score: 7.05349561279366
Financial ratios for CLV.AX — annual report dated 2023-07-31
Total revenue: 53250000
Gross profit: 15825333.333333334
Operating income: 5576666.666666667
Net income: 4136666.6666666665
Capital expenditures: 1092666.6666666667
Depreciation & amortization: 612666.6666666666
Net tangible assets: 43496000
Owner earnings: 3656666.666666666
Return on net tangible assets (%): 8.406903316780086
Capex to operating income (%): 19.593544530783024
Buffett classification: The Great
Stock price: 0.6866666666666666
P/E ratio: 27.721083195809832
Shares outstanding: 166999341
Book value: 44767333.333333336
P/B ratio: 2.561530300814582
Market cap (USD): 114672880.82
Debt to equity: 0.17441289035159566
Current ratio: 7.239232718060079
Quick ratio: 2.790324526480878
Effective tax rate (%): 25.786389187896187
Interest coverage ratio: 11.45890410958904
COGS to revenue (%): 70.2810641627543
R&D to revenue (%): 3.220031298904538
SG&A to revenue (%): 14.028169014084508
Free cash flow (dilution-adjusted): 3398000
Buyback yield (%): 0
Retained earnings: 21157333.333333332
Inventory turnover: 1.5222767578707594
Receivables turnover: 6.685219283562103
Capitalized R&D asset: 2584729.603729604
ROCI (R&D-adjusted, %): 11.529960976204638
Rosenberg metric: 0.5913983126907202
FCF margin (%): 6.381220657276995
Revenue growth (%): 7.766062836116616
Rule of 40 score: 14.147283493393612
Financial ratios for CLV.AX — annual report dated 2024-07-31
Total revenue: 40658169.93464052
Gross profit: 11020915.032679738
Operating income: 1284313.7254901961
Net income: 990196.0784313725
Capital expenditures: 1521568.6274509805
Depreciation & amortization: 761437.908496732
Net tangible assets: 42590196.078431375
Owner earnings: 230065.35947712394
Return on net tangible assets (%): 0.5401838466614484
Capex to operating income (%): 118.47328244274809
Buffett classification: The Gruesome
Stock price: 0.3006535947712418
P/E ratio: 50.70607053465346
Shares outstanding: 166999341
Book value: 43836601.30718954
P/B ratio: 1.1453659886685554
Market cap (USD): 50208952.19607843
Debt to equity: 0.1548680483077382
Current ratio: 5.785881395585393
Quick ratio: 2.779676533414708
Effective tax rate (%): 20.970266040688575
Interest coverage ratio: 2.1857619577308123
COGS to revenue (%): 72.89372578648705
R&D to revenue (%): 4.0075875705306485
SG&A to revenue (%): 16.676579806131144
Free cash flow (dilution-adjusted): 4003921.568627451
Buyback yield (%): 0
Retained earnings: 20914379.08496732
Inventory turnover: 1.53431007647019
Receivables turnover: 4.53701407628911
Capitalized R&D asset: 3206776.892911011
ROCI (R&D-adjusted, %): 2.630303887398758
Rosenberg metric: -2.8019546854511637
FCF margin (%): 9.847766328548236
Revenue growth (%): -23.64662923072203
Rule of 40 score: -13.798862902173795
Financial ratios for CMTL — annual report dated 2021-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.9
Shares outstanding: 29961431
Market cap (USD): 716078200.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMTL — annual report dated 2022-07-31
Total revenue: 486239000
Gross profit: 179836000
Operating income: -8950000
Net income: -33052000
Capital expenditures: 19619000
Operating cash flow: 1997000
Depreciation & amortization: 31710000
Net tangible assets: -23206000
Owner earnings: -20961000
Buffett classification: The Gruesome
Stock price: 11.42
Shares outstanding: 29961431
Book value: 571789000
P/B ratio: 0.5984017566270076
Market cap (USD): 342159542.02
Debt to equity: 0.3202370105056236
Current ratio: 1.3611862067539557
Quick ratio: 0.8633132944271854
Interest coverage ratio: -1.7789703836215465
COGS to revenue (%): 63.01489596679822
R&D to revenue (%): 10.803740547344
SG&A to revenue (%): 23.62171689231016
Free cash flow (dilution-adjusted): -32777000
Buyback yield (%): 0
Retained earnings: 278683000
Inventory turnover: 3.1811933511218164
Receivables turnover: 3.9304427253841614
Capitalized R&D asset: 52532000
ROCI (R&D-adjusted, %): 3.1284148415513515
FCF margin (%): -6.740923702130022
Rule of 40 score: -6.740923702130022
Financial ratios for CMTL — annual report dated 2023-07-31
Total revenue: 549994000
Gross profit: 184460000
Operating income: -5570000
Net income: -26899000
Capital expenditures: 18311000
Operating cash flow: -4433000
Depreciation & amortization: 33318000
Net tangible assets: -23089000
Owner earnings: -11892000
Buffett classification: The Gruesome
Stock price: 10.16
Shares outstanding: 29961431
Book value: 550510000
P/B ratio: 0.5529566019872482
Market cap (USD): 304408138.96
Debt to equity: 0.3902054458592941
Current ratio: 1.44117563806199
Quick ratio: 0.9418361088833326
Interest coverage ratio: -0.3441032927657997
COGS to revenue (%): 66.46145230675243
R&D to revenue (%): 8.842096459234101
SG&A to revenue (%): 21.81896529780325
Free cash flow (dilution-adjusted): -36615000
Buyback yield (%): 0
Retained earnings: 238913000
Inventory turnover: 3.4534838679200717
Receivables turnover: 3.370908132557812
Capitalized R&D asset: 83827440
ROCI (R&D-adjusted, %): 1.0759198043014766
Rosenberg metric: 0.08802253864311277
FCF margin (%): -6.657345352858394
Revenue growth (%): 13.111864741413173
Rule of 40 score: 6.454519388554779
Financial ratios for CMTL — annual report dated 2024-07-31
Total revenue: 540403000
Gross profit: 157179000
Operating income: -11250000
Net income: -99985000
Capital expenditures: 13083000
Operating cash flow: -54495000
Depreciation & amortization: 33313000
Net tangible assets: 7321000
Owner earnings: -79755000
Return on net tangible assets (%): -1089.4003551427402
Buffett classification: The Gruesome
Stock price: 3.24
Shares outstanding: 29961431
Book value: 486329000
P/B ratio: 0.19960774792373065
Market cap (USD): 97075036.44000001
Debt to equity: 0.4435351377359771
Current ratio: 1.8335957547658093
Quick ratio: 1.3261725879475013
Interest coverage ratio: -0.49275108405238494
COGS to revenue (%): 70.91448419050226
R&D to revenue (%): 4.455378671102863
SG&A to revenue (%): 22.797430806268654
Free cash flow (dilution-adjusted): -73674000
Buyback yield (%): 0
Retained earnings: 103580000
Inventory turnover: 4.114671018725305
Receivables turnover: 2.7628671489557504
Capitalized R&D asset: 73995330
ROCI (R&D-adjusted, %): -3.6019807120013048
Rosenberg metric: -0.5609796220517776
FCF margin (%): -13.633158957296684
Revenue growth (%): -1.7438372054967872
Rule of 40 score: -15.376996162793471
Financial ratios for CMTL — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.72
Shares outstanding: 29961431
Market cap (USD): 111456523.32000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMTL — quarterly report dated 2025-01-31
Total revenue: 126574000
Gross profit: 33740000
Operating income: -9489000
Net income: -22356000
Capital expenditures: 1653000
Operating cash flow: -234000
Depreciation & amortization: 7822000
Net tangible assets: -136792000
Owner earnings: -16187000
Buffett classification: The Gruesome
Stock price: 2
Shares outstanding: 29961431
Book value: 251025000
P/B ratio: 0.23871272582412112
Market cap (USD): 59922862
Debt to equity: 1.0006692560501942
Current ratio: 0.7514670044042574
Quick ratio: 0.5402053935931941
Interest coverage ratio: -0.8620094476744186
COGS to revenue (%): 73.34365667514655
R&D to revenue (%): 3.4398849684769384
SG&A to revenue (%): 26.72902807843633
Free cash flow (dilution-adjusted): -3057000
Buyback yield (%): 0
Retained earnings: -48739000
Inventory turnover: 1.1404528199899264
Receivables turnover: 0.7570351142664044
Capitalized R&D asset: 4354000
ROCI (R&D-adjusted, %): -1.690511268649182
FCF margin (%): -2.4151879532921456
Rule of 40 score: -2.4151879532921456
Financial ratios for CMTL — quarterly report dated 2025-04-30
Total revenue: 126787000
Gross profit: 38945000
Operating income: -727000
Net income: 33934000
Capital expenditures: 2461000
Operating cash flow: 2301000
Depreciation & amortization: 7770000
Net tangible assets: -97268000
Owner earnings: 39243000
Return on net tangible assets (%): -40.34523173088785
Buffett classification: The Gruesome
Stock price: 1.37
P/E ratio: 0.30240437665762954
Shares outstanding: 29961431
Book value: 285505000
P/B ratio: 0.1437703734435474
Market cap (USD): 41047160.470000006
Debt to equity: 0.8809758147843295
Current ratio: 0.7369802217970769
Quick ratio: 0.5285161920452502
Effective tax rate (%): -5.604829925621635
Interest coverage ratio: -0.056326024637793445
COGS to revenue (%): 69.28312839644443
R&D to revenue (%): 3.49010545245175
SG&A to revenue (%): 23.821842933423774
Free cash flow (dilution-adjusted): -1355000
Buyback yield (%): 0
Retained earnings: -14805000
Inventory turnover: 1.1306586348483094
Receivables turnover: 0.8370325868807437
Capitalized R&D asset: 7342180
ROCI (R&D-adjusted, %): 0.20001563145919804
Rosenberg metric: 1.1954524575103354
FCF margin (%): -1.068721556626468
Revenue growth (%): 0.16828100557776476
Rule of 40 score: -0.9004405510487032
Financial ratios for CMTL — quarterly report dated 2025-07-31
Total revenue: 130367000
Gross profit: 40673000
Operating income: 2906000
Net income: 7910000
Capital expenditures: 2036000
Operating cash flow: 11447000
Depreciation & amortization: 8441000
Net tangible assets: -83763000
Owner earnings: 14315000
Return on net tangible assets (%): -17.08988455523322
Capex to operating income (%): 70.06194081211287
Buffett classification: The Good
Stock price: 2.17
P/E ratio: 3.3362225610632184
Shares outstanding: 29961431
Book value: 293967000
P/B ratio: 0.22116872053665887
Market cap (USD): 65016305.269999996
Debt to equity: 0.8527419744393078
Current ratio: 1.707347281815367
Quick ratio: 1.2716099311843994
Effective tax rate (%): 6.556408741878323
Interest coverage ratio: 0.23515131898365432
COGS to revenue (%): 68.80115366618853
R&D to revenue (%): 3.7708929406981824
SG&A to revenue (%): 21.330551443233333
Free cash flow (dilution-adjusted): 8811000
Buyback yield (%): 0
Retained earnings: -6895000
Inventory turnover: 1.3007613661083315
Receivables turnover: 0.9000945890898044
Capitalized R&D asset: 9317570
ROCI (R&D-adjusted, %): 0.5502585497161303
Rosenberg metric: 0.3905084745762712
FCF margin (%): 6.7586122254865115
Revenue growth (%): 2.8236333378027716
Rule of 40 score: 9.582245563289284
Financial ratios for CMTL — annual report dated 2025-07-31
Total revenue: 499528000
Gross profit: 127874000
Operating income: -54744000
Net income: -155302000
Capital expenditures: 8565000
Operating cash flow: -8292000
Depreciation & amortization: 33521000
Net tangible assets: -83763000
Owner earnings: -130346000
Buffett classification: The Gruesome
Stock price: 2.17
Shares outstanding: 29961431
Book value: 293967000
P/B ratio: 0.22116872053665887
Market cap (USD): 65016305.269999996
Debt to equity: 0.8527419744393078
Current ratio: 1.707347281815367
Quick ratio: 1.2716099311843994
Interest coverage ratio: -1.195153367536295
COGS to revenue (%): 74.40103457664034
R&D to revenue (%): 3.4848897359107
SG&A to revenue (%): 28.72451594305024
Free cash flow (dilution-adjusted): -19977000
Buyback yield (%): 0
Retained earnings: -6895000
Inventory turnover: 5.389804945254151
Receivables turnover: 3.448897726409688
Capitalized R&D asset: 49587820
ROCI (R&D-adjusted, %): -10.657617341171557
Rosenberg metric: -1.2171366864642605
FCF margin (%): -3.99917522140901
Revenue growth (%): -7.563799608810462
Rule of 40 score: -11.562974830219472
Financial ratios for CMTL — quarterly report dated 2025-10-31
Total revenue: 111032000
Gross profit: 36766000
Operating income: -2006000
Net income: -15879000
Capital expenditures: 3256000
Operating cash flow: 8076000
Depreciation & amortization: 8044000
Net tangible assets: -93644000
Owner earnings: -11091000
Buffett classification: The Gruesome
Stock price: 2.84
P/E ratio: 23.57729676918814
Shares outstanding: 29961431
Book value: 279042000
P/B ratio: 0.30493783745816044
Market cap (USD): 85090464.03999999
Debt to equity: 0.9256420180474624
Current ratio: 1.698744663225642
Quick ratio: 1.2664181482189512
Interest coverage ratio: -0.17363455379555093
COGS to revenue (%): 66.88702356077528
R&D to revenue (%): 3.4134303624180413
SG&A to revenue (%): 26.963397939332808
Free cash flow (dilution-adjusted): 3693000
Buyback yield (%): 0
Retained earnings: -22774000
Inventory turnover: 1.0946421991303708
Receivables turnover: 0.7915309214043842
Capitalized R&D asset: 8543970
ROCI (R&D-adjusted, %): -0.442692439367995
Rosenberg metric: -0.7947518307567127
FCF margin (%): 3.3260681605302973
Revenue growth (%): -14.831207284051946
Rule of 40 score: -11.505139123521648
Financial ratios for CMTL — quarterly report dated 2026-01-31
Total revenue: 106761000
Gross profit: 36223000
Operating income: -931000
Net income: -13635000
Capital expenditures: 4428000
Operating cash flow: 4870000
Depreciation & amortization: 8008000
Net tangible assets: -102064000
Owner earnings: -10055000
Buffett classification: The Gruesome
Stock price: 5.56
P/E ratio: 13.510588512570964
Shares outstanding: 29961431
Book value: 265579000
P/B ratio: 0.6272542496206401
Market cap (USD): 166585556.35999998
Debt to equity: 0.9512235530670723
Current ratio: 1.6863479966220696
Quick ratio: 1.2256862293503068
Interest coverage ratio: -0.08294725588025659
COGS to revenue (%): 66.07094350933393
R&D to revenue (%): 4.149455325446558
SG&A to revenue (%): 25.928007418439318
Free cash flow (dilution-adjusted): 30000
Buyback yield (%): 0
Retained earnings: -36409000
Inventory turnover: 1.0686766154079237
Receivables turnover: 0.8349117469950185
Capitalized R&D asset: 8591580
ROCI (R&D-adjusted, %): -0.154561339398229
Rosenberg metric: -0.14327176781002637
FCF margin (%): 0.028100148930789333
Revenue growth (%): -3.846638806830463
Rule of 40 score: -3.8185386578996736
Financial ratios for COST.TO — annual report dated 2022-08-31
Total revenue: 226954000000
Gross profit: 27572000000
Operating income: 7793000000
Net income: 5915000000
Capital expenditures: 3891000000
Operating cash flow: 7392000000
Depreciation & amortization: 1900000000
Net tangible assets: 20642000000
Owner earnings: 3924000000
Return on net tangible assets (%): 19.009785873461873
Capex to operating income (%): 49.929423841909404
Buffett classification: The Good
Stock price: 18.335877862595417
P/E ratio: 40.55342679936504
Shares outstanding: 13082194445
Book value: 20647000000
P/B ratio: 11.617838887889002
Market cap (USD): 239873519518.24423
Debt to equity: 0.4377875720443648
Current ratio: 1.0218138633664604
Quick ratio: 0.4621851365710357
Effective tax rate (%): 24.553571428571427
Interest coverage ratio: 49.322784810126585
COGS to revenue (%): 87.85128263877262
SG&A to revenue (%): 8.714981890603383
Free cash flow (dilution-adjusted): 2777000000
Buyback yield (%): 0.1830131149456081
Retained earnings: 15585000000
Inventory turnover: 11.13430502038309
Receivables turnover: 101.2735385988398
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.22593882118876
FCF margin (%): 1.223595970989716
Rule of 40 score: 1.223595970989716
Financial ratios for COST.TO — annual report dated 2023-08-31
Total revenue: 242290000000
Gross profit: 29704000000
Operating income: 8114000000
Net income: 6292000000
Capital expenditures: 4323000000
Operating cash flow: 11068000000
Depreciation & amortization: 2077000000
Net tangible assets: 25058000000
Owner earnings: 4046000000
Return on net tangible assets (%): 16.14654002713704
Capex to operating income (%): 53.278284446635446
Buffett classification: The Good
Stock price: 18.474074074074075
P/E ratio: 38.4109073789527
Shares outstanding: 13082194445
Book value: 25058000000
P/B ratio: 9.644881045110159
Market cap (USD): 241681429228.3704
Debt to equity: 0.354537473062495
Current ratio: 1.0683679242473871
Quick ratio: 0.5725515886013757
Effective tax rate (%): 25.863084717803698
Interest coverage ratio: 50.7125
COGS to revenue (%): 87.74031119732551
SG&A to revenue (%): 8.910809360683478
Free cash flow (dilution-adjusted): 5971000000
Buyback yield (%): 0.27970705161679255
Retained earnings: 19521000000
Inventory turnover: 12.767161131463576
Receivables turnover: 106.03501094091904
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.91378385247522
FCF margin (%): 2.464402162697594
Revenue growth (%): 6.757316460604351
Rule of 40 score: 9.221718623301946
Financial ratios for COST.TO — annual report dated 2024-08-31
Total revenue: 254453000000
Gross profit: 32095000000
Operating income: 9285000000
Net income: 7367000000
Capital expenditures: 4710000000
Operating cash flow: 11339000000
Depreciation & amortization: 2237000000
Net tangible assets: 23622000000
Owner earnings: 4894000000
Return on net tangible assets (%): 20.717974769282872
Capex to operating income (%): 50.72697899838449
Buffett classification: The Good
Stock price: 30.42222222222222
P/E ratio: 54.023269520851244
Shares outstanding: 13082194445
Book value: 23622000000
P/B ratio: 16.848252754216876
Market cap (USD): 397989426560.1111
Debt to equity: 0.3458216916433833
Current ratio: 0.965655312429506
Quick ratio: 0.4398545003383713
Effective tax rate (%): 24.363449691991786
Interest coverage ratio: 54.94082840236686
COGS to revenue (%): 87.38666865786608
SG&A to revenue (%): 8.964327400345054
Free cash flow (dilution-adjusted): 5811000000
Buyback yield (%): 0.17588406959707864
Retained earnings: 17619000000
Inventory turnover: 11.924599131227543
Receivables turnover: 93.51451672179346
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 27.017196729420668
FCF margin (%): 2.2837223377205222
Revenue growth (%): 5.020017334599034
Rule of 40 score: 7.303739672319557
Financial ratios for COST.TO — quarterly report dated 2024-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 32.01428571428572
Shares outstanding: 13082194445
Market cap (USD): 418817110732.0715
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COST.TO — quarterly report dated 2025-02-28
Total revenue: 63723000000
Gross profit: 7979000000
Operating income: 2316000000
Net income: 1788000000
Capital expenditures: 1137000000
Operating cash flow: 2748000000
Depreciation & amortization: 552000000
Net tangible assets: 25577000000
Owner earnings: 1203000000
Return on net tangible assets (%): 4.703444500918795
Capex to operating income (%): 49.09326424870466
Buffett classification: The Good
Stock price: 33.333333333333336
P/E ratio: 60.97219633202834
Shares outstanding: 13082194445
Book value: 25577000000
P/B ratio: 17.04942519320744
Market cap (USD): 436073148166.6667
Debt to equity: 0.3143058216366267
Current ratio: 0.9972431687342901
Quick ratio: 0.4903646044487689
Effective tax rate (%): 26.176713459950452
Interest coverage ratio: 64.33333333333333
COGS to revenue (%): 87.47861839524191
SG&A to revenue (%): 8.886901118905262
Free cash flow (dilution-adjusted): 1460000000
Buyback yield (%): 0.04701046163054489
Retained earnings: 19770000000
Inventory turnover: 2.97237922576517
Receivables turnover: 20.82450980392157
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.393374741200828
FCF margin (%): 2.291166454812234
Rule of 40 score: 2.291166454812234
Financial ratios for COST.TO — quarterly report dated 2025-05-31
Total revenue: 63205000000
Gross profit: 8209000000
Operating income: 2530000000
Net income: 1903000000
Capital expenditures: 1131000000
Operating cash flow: 3460000000
Depreciation & amortization: 552000000
Net tangible assets: 27125000000
Owner earnings: 1324000000
Return on net tangible assets (%): 4.881105990783411
Capex to operating income (%): 44.70355731225296
Buffett classification: The Good
Stock price: 34.22463768115942
P/E ratio: 58.81941210648994
Shares outstanding: 13082194445
Book value: 27125000000
P/B ratio: 16.506299168833234
Market cap (USD): 447733364954.60144
Debt to equity: 0.30156682027649767
Current ratio: 1.0152212671971048
Quick ratio: 0.5201043135793928
Effective tax rate (%): 26.24031007751938
Interest coverage ratio: 72.28571428571429
COGS to revenue (%): 87.01210347282652
SG&A to revenue (%): 8.985048651214303
Free cash flow (dilution-adjusted): 2223000000
Buyback yield (%): 0.04712626230600318
Retained earnings: 20890000000
Inventory turnover: 2.9558207029990324
Receivables turnover: 21.984347826086957
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.6749333825818535
FCF margin (%): 3.517126809587849
Revenue growth (%): -0.8128933038306421
Rule of 40 score: 2.704233505757207
Financial ratios for COST.TO — quarterly report dated 2025-08-31
Total revenue: 86156000000
Gross profit: 11119000000
Operating income: 3341000000
Net income: 2610000000
Capital expenditures: 1966000000
Operating cash flow: 3867000000
Depreciation & amortization: 774000000
Net tangible assets: 29164000000
Owner earnings: 1418000000
Return on net tangible assets (%): 4.862158825949801
Capex to operating income (%): 58.84465728823706
Buffett classification: The Good
Stock price: 31.182481751824813
P/E ratio: 64.7413568568539
Shares outstanding: 13082194445
Book value: 29164000000
P/B ratio: 13.987631653923893
Market cap (USD): 407935289555.03644
Debt to equity: 0.2802427650528048
Current ratio: 1.0342783227336423
Quick ratio: 0.5460817074485286
Effective tax rate (%): 25.64102564102564
Interest coverage ratio: 72.6304347826087
COGS to revenue (%): 87.0943404986304
SG&A to revenue (%): 9.027810019035238
Free cash flow (dilution-adjusted): 1761000000
Buyback yield (%): 0.06863833729742175
Retained earnings: 22650000000
Inventory turnover: 4.142029145506735
Receivables turnover: 26.898532625663442
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.354379735440475
FCF margin (%): 2.043966757973908
Revenue growth (%): 36.31200063286133
Rule of 40 score: 38.35596739083523
Financial ratios for COST.TO — annual report dated 2025-08-31
Total revenue: 275235000000
Gross profit: 35349000000
Operating income: 10383000000
Net income: 8099000000
Capital expenditures: 5498000000
Operating cash flow: 13335000000
Depreciation & amortization: 2426000000
Net tangible assets: 29164000000
Owner earnings: 5027000000
Return on net tangible assets (%): 17.237004526128104
Capex to operating income (%): 52.95194067225272
Buffett classification: The Good
Stock price: 31.182481751824813
P/E ratio: 50.3685997721986
Shares outstanding: 13082194445
Book value: 29164000000
P/B ratio: 13.987631653923893
Market cap (USD): 407935289555.03644
Debt to equity: 0.2802427650528048
Current ratio: 1.0342783227336423
Quick ratio: 0.5460817074485286
Effective tax rate (%): 25.134035866149013
Interest coverage ratio: 67.42207792207792
COGS to revenue (%): 87.15679328573765
SG&A to revenue (%): 9.070794048722002
Free cash flow (dilution-adjusted): 6977000000
Buyback yield (%): 0.22135863778418516
Retained earnings: 22650000000
Inventory turnover: 13.241664826672555
Receivables turnover: 85.93037777083984
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.963341751894177
FCF margin (%): 2.534924700710302
Revenue growth (%): 8.167323631476146
Rule of 40 score: 10.702248332186448
Financial ratios for COST.TO — quarterly report dated 2025-11-30
Total revenue: 67307000000
Gross profit: 8797000000
Operating income: 2463000000
Net income: 2001000000
Capital expenditures: 1526000000
Operating cash flow: 4688000000
Depreciation & amortization: 597000000
Net tangible assets: 30303000000
Owner earnings: 1072000000
Return on net tangible assets (%): 3.5376035376035375
Capex to operating income (%): 61.956963053187174
Buffett classification: The Good
Stock price: 29.428571428571434
P/E ratio: 46.373198466290404
Shares outstanding: 13082194445
Book value: 30303000000
P/B ratio: 12.704692395708113
Market cap (USD): 384990293667.14294
Debt to equity: 0.26736626736626734
Current ratio: 1.0384164573615595
Quick ratio: 0.5327113981581151
Effective tax rate (%): 22.531939605110338
Interest coverage ratio: 70.37142857142857
COGS to revenue (%): 86.93003699466622
SG&A to revenue (%): 9.410611080571114
Free cash flow (dilution-adjusted): 2676000000
Buyback yield (%): 0.054546829739443504
Retained earnings: 23869000000
Inventory turnover: 2.767607965564543
Receivables turnover: 20.831631073970907
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.009515676467
FCF margin (%): 3.975812322641033
Revenue growth (%): -21.877756627512884
Rule of 40 score: -17.90194430487185
Financial ratios for COST.TO — quarterly report dated 2026-02-28
Total revenue: 69597000000
Gross profit: 8878000000
Operating income: 2606000000
Net income: 2035000000
Capital expenditures: 1289000000
Operating cash flow: 2996000000
Depreciation & amortization: 597000000
Net tangible assets: 32087000000
Owner earnings: 1343000000
Return on net tangible assets (%): 4.185495683610185
Capex to operating income (%): 49.46277820414428
Buffett classification: The Good
Stock price: 33.05839416058394
P/E ratio: 50.58794484129273
Shares outstanding: 13082194445
Book value: 32087000000
P/B ratio: 13.478241669467748
Market cap (USD): 432476340448.2116
Debt to equity: 0.2544644248449528
Current ratio: 1.058140961165763
Quick ratio: 0.5922527782547898
Effective tax rate (%): 25.211319367879454
Interest coverage ratio: 78.96969696969697
COGS to revenue (%): 87.24370303317673
SG&A to revenue (%): 9.011882696093222
Free cash flow (dilution-adjusted): 1541000000
Buyback yield (%): 0.04832634307425829
Retained earnings: 25121000000
Inventory turnover: 3.1972513295771683
Receivables turnover: 18.40216816499207
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.077992350032653
FCF margin (%): 2.214175898386425
Revenue growth (%): 3.4023207095844414
Rule of 40 score: 5.616496607970866
Financial ratios for CRST.L — annual report dated 2021-10-31
Capital expenditures: 277777.7777777778
Buffett classification: The Gruesome
Stock price: 0.03902777777777778
Shares outstanding: 256744461
Market cap (USD): 10020165.769583333
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRST.L — annual report dated 2022-10-31
Total revenue: 1062325581.3953489
Gross profit: 106744186.04651164
Operating income: 49069767.44186047
Net income: 30697674.418604653
Capital expenditures: 116279.06976744186
Operating cash flow: 60116279.069767445
Depreciation & amortization: 2674418.604651163
Net tangible assets: 993139534.883721
Owner earnings: 33255813.953488376
Return on net tangible assets (%): 3.348554033485541
Capex to operating income (%): 0.23696682464454974
Buffett classification: The Great
Stock price: 0.019651162790697674
P/E ratio: 0.1643553557159091
Shares outstanding: 256744461
Book value: 1026860465.1162791
P/B ratio: 0.004913352271430188
Market cap (USD): 5045327.19872093
Debt to equity: 0.11436983354093533
Current ratio: 3.082553545435642
Quick ratio: 1.0237055520898315
Effective tax rate (%): 19.51219512195122
Interest coverage ratio: 4.019047619047619
COGS to revenue (%): 89.95183887915937
SG&A to revenue (%): 5.593257443082312
Free cash flow (dilution-adjusted): 57790697.674418606
Buyback yield (%): 25.35157219864996
Retained earnings: 925697674.4186046
Inventory turnover: 0.8300171699828299
Receivables turnover: 18.493927125506076
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8423017390512606
FCF margin (%): 5.440017513134851
Rule of 40 score: 5.440017513134851
Financial ratios for CRST.L — annual report dated 2023-10-31
Total revenue: 801829268.292683
Gross profit: 103292682.92682928
Operating income: 36219512.19512195
Net income: 21829268.292682927
Capital expenditures: 2195121.951219512
Operating cash flow: -201951219.51219514
Depreciation & amortization: 3414634.1463414636
Net tangible assets: 1008902439.0243903
Owner earnings: 23048780.487804875
Return on net tangible assets (%): 2.284540070107578
Capex to operating income (%): 6.0606060606060606
Buffett classification: The Great
Stock price: 0.01780487804878049
P/E ratio: 0.20941168327374302
Shares outstanding: 256744461
Book value: 1044268292.6829268
P/B ratio: 0.004377518545603178
Market cap (USD): 4571303.817804879
Debt to equity: 0.12156954338432793
Current ratio: 3.3289263733758827
Quick ratio: 0.6738089810804647
Effective tax rate (%): 22.51082251082251
Interest coverage ratio: 2.1838235294117645
COGS to revenue (%): 87.11787072243345
SG&A to revenue (%): 8.8212927756654
Free cash flow (dilution-adjusted): -205975609.75609756
Buyback yield (%): 26.677557294967897
Retained earnings: 938170731.7073171
Inventory turnover: 0.49175824175824173
Receivables turnover: 11.657801418439716
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.720776841333822
FCF margin (%): -25.68821292775665
Revenue growth (%): -24.52132544530349
Rule of 40 score: -50.20953837306014
Financial ratios for CRST.L — annual report dated 2024-10-31
Total revenue: 802857142.8571428
Gross profit: -95714285.71428572
Operating income: -170000000
Net income: -136363636.36363637
Capital expenditures: 1818181.8181818181
Operating cash flow: -88051948.05194806
Depreciation & amortization: 3506493.5064935065
Net tangible assets: 900649350.6493506
Owner earnings: -134675324.67532468
Return on net tangible assets (%): -14.953136265320838
Buffett classification: The Gruesome
Stock price: 0.021298701298701296
Shares outstanding: 256744461
Book value: 938311688.3116883
P/B ratio: 0.005827832747958477
Market cap (USD): 5468323.584935064
Debt to equity: 0.13051903114186852
Current ratio: 3.253735059760956
Quick ratio: 0.44223107569721115
Interest coverage ratio: -7.1923076923076925
COGS to revenue (%): 111.92170818505338
SG&A to revenue (%): 9.835004852798448
Free cash flow (dilution-adjusted): -92207792.20779221
Buyback yield (%): 2.374953271381288
Retained earnings: 825324675.3246753
Inventory turnover: 0.6127889469488974
Receivables turnover: 12.463709677419354
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.657126281183523
FCF margin (%): -11.484956324813977
Revenue growth (%): 0.12819120043453025
Rule of 40 score: -11.356765124379447
Financial ratios for CRST.L — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 900649350.6493506
Buffett classification: The Gruesome
Stock price: 0.021298701298701296
Shares outstanding: 256744461
Book value: 938311688.3116883
P/B ratio: 0.005827832747958477
Market cap (USD): 5468323.584935064
Debt to equity: 0.13051903114186852
Current ratio: 3.253735059760956
Quick ratio: 0.44223107569721115
Buyback yield (%): 0
Retained earnings: 825324675.3246753
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRST.L — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 938933333.3333334
Buffett classification: The Gruesome
Stock price: 0.023333333333333334
Shares outstanding: 256744461
Market cap (USD): 5990704.09
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CWV.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.14960629921259844
Shares outstanding: 312903038
Market cap (USD): 46812265.52755906
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CWV.V — annual report dated 2022-12-31
Total revenue: 24294573.529411763
Gross profit: 14173341.911764706
Operating income: -963163.9705882352
Net income: -4343234.558823529
Capital expenditures: 7612223.529411764
Operating cash flow: 981481.6176470588
Depreciation & amortization: 5329534.558823529
Net tangible assets: 19044361.76470588
Owner earnings: -6625923.529411764
Return on net tangible assets (%): -34.792048225482205
Buffett classification: The Gruesome
Stock price: 0.11764705882352941
Shares outstanding: 312903038
Book value: 19044361.76470588
P/B ratio: 1.9329669627400916
Market cap (USD): 36812122.11764706
Debt to equity: 0.7769015856630718
Current ratio: 0.8855711644227728
Quick ratio: 0.743138950218463
Interest coverage ratio: -0.4785878202437179
COGS to revenue (%): 39.12095172548215
SG&A to revenue (%): 11.04261058055206
Free cash flow (dilution-adjusted): -6685692.647058823
Buyback yield (%): 0
Retained earnings: -9537244.117647057
Inventory turnover: 8.157186933410577
Receivables turnover: 6.366796929195764
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.2957266283243754
FCF margin (%): -27.519283839104713
Rule of 40 score: -27.519283839104713